Vineet Laboratories Limited (NSE:VINEETLAB)

Market Cap	700.45M +126.0%
Revenue (ttm)	560.13M -43.4%
Net Income	-101.39M
EPS	-11.04
Shares Out	19.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70,189
Average Volume	168,886
Open	36.48
Previous Close	38.38
Day's Range	36.47 - 36.48
52-Week Range	26.97 - 49.99
Beta	0.14
RSI	51.01
Earnings Date	May 12, 2026

About Vineet Laboratories

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl th...

• Industry: Chemicals
• Sector: Materials
• Founded: 2016
• Employees: 57
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VINEETLAB